Green Thumb Industries vs. Cresco Labs: Mid-Tier MSO Showdown After Q1 2026 Earnings Season
By Sheeba M. | April 19, 2026 Green Thumb Industries vs. Cresco Labs: Mid-Tier MSO Showdown After Q1 2026 Earnings Season TL;DR: Both Green Thumb and Cresco Labs beat Q1 estimates, but their paths are diverging — GTBIF is doubling down on retail branding while CRLBF is chasing wholesale scale. The smarter bet in 2026: […]
Verano Holdings Posts Q1 2026: $280M Revenue and the Path to Becoming the US’s #2 Cannabis Operator
By Sheeba M. | April 19, 2026 Verano Holdings Posts Q1 2026: $280M Revenue and the Path to Becoming the US’s #2 Cannabis Operator TL;DR: Verano’s Q1 2026 numbers confirm the MSO is firing on all cylinders — $280M in revenue, positive EBITDA, and aggressive store growth. With recent acquisitions stacking its footprint, VRNO may […]
Bipartisan Senate Bill Could Shield Hemp THC Products — And Reshape the Cannabis Market
By Sheeba M. | April 19, 2026 Bipartisan Senate Bill Could Shield Hemp THC Products — And Reshape the Cannabis Market TL;DR: A new bipartisan Senate bill would let states opt out of a federal crackdown on hemp-derived THC products. If passed, it protects the booming delta-8 and hemp THC market — and removes a […]
Tilray Brands Posts Record Q3 Fiscal 2026: $207 Million Revenue Signals MSO Turnaround Is Real
By Sheeba M. | April 19, 2026 Tilray Brands Posts Record Q3 Fiscal 2026: $207 Million Revenue Signals MSO Turnaround Is Real TL;DR: Tilray just posted $207 million in Q3 fiscal 2026 revenue — a new record. With 11% organic growth and expanding gross margins, the Canadian giant is proving that scale + efficiency = […]
Cannabis Rescheduling Update: What the DEA’s Latest Move Actually Means for Your Stocks
By Sheeba M. | April 18, 2026 Cannabis Rescheduling Update: What the DEA’s Latest Move Actually Means for Your Stocks TL;DR: The DEA’s proposed rescheduling to Schedule III is real progress, but it doesn’t solve the core banking, tax, or listing problems cannabis companies face. Here’s what actually changes — and what doesn’t. After years […]
Cannabis M&A Heats Up: 3 Takeover Targets Wall Street Is Watching
By Sheeba M. | April 18, 2026 Cannabis M&A Heats Up: 3 Takeover Targets Wall Street Is Watching TL;DR: With MSO balance sheets stabilizing and institutional capital returning, a new wave of cannabis M&A is inevitable. These three mid-tier operators look like prime acquisition candidates. The cannabis sector is quietly positioning itself for its next […]
Curaleaf’s International Push: Can a US-Centric MSO Win in European Cannabis Markets?
By Sheeba M. | April 18, 2026 Curaleaf’s International Push: Can a US-Centric MSO Win in European Cannabis Markets? TL;DR: Curaleaf has been aggressively acquiring European cannabis assets — but EU cannabis markets operate under entirely different regulatory rules than US state markets. The opportunity is massive; so is the execution risk. Curaleaf Holdings (CSE: […]
Cresco Labs Expansion Strategy: Why the Vertical Integration Play Could Pay Off in 2026
By Sheeba M. | April 18, 2026 Cresco Labs Expansion Strategy: Why the Vertical Integration Play Could Pay Off in 2026 TL;DR: Cresco Labs is doubling down on full vertical integration across its retail and wholesale arms — a strategy that’s compressing margins today but sets up a powerful cost advantage as cannabis markets mature […]
The Cannabis M&A Wave Is Building Again — and This Time the Targets Look Different
By Sheeba M. | April 18, 2026 The Cannabis M&A Wave Is Building Again — and This Time the Targets Look Different TL;DR: After a two-year deal-making drought, cannabis M&A is perking up — but the strategic logic has changed. Buyers want profitable assets, not just revenue scale. That’s great news for holders of well-run […]
Small-Cap Cannabis Operators Are Quietly Outperforming the Big MSOs — Here’s Why
By Sheeba M. | April 18, 2026 Small-Cap Cannabis Operators Are Quietly Outperforming the Big MSOs — Here’s Why TL;DR: While Curaleaf and Trulieve fight margin compression, a cohort of sub-$500M cannabis operators are posting 30%+ revenue growth with leaner cost structures. The market is starting to notice. The cannabis industry’s center of gravity may […]